Baker McKenzie advised Xbrane Biopharma on the deal.Xbrane Biopharma AB (publ) executed a primary issuance of shares of approximately SEK 170 million at a subscription price of…
Xbrane Biopharma’s Shares Offering
Baker McKenzie advised Xbrane Biopharma on the deal.Xbrane Biopharma AB (publ) executed a primary issuance of shares of approximately SEK 170 million at a subscription price of…